| Symbol |
Name |
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AKR1C4
|
aldo-keto reductase family 1, member C4
|
|
AQP1
|
aquaporin 1 (Colton blood group)
|
|
AQP5
|
aquaporin 5
|
|
AREG
|
amphiregulin
|
|
ATP7A
|
ATPase, Cu++ transporting, alpha polypeptide
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BGLAP
|
bone gamma-carboxyglutamate (gla) protein
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL3
|
chemokine (C-C motif) ligand 3
|
|
CCND1
|
cyclin D1
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CGB
|
chorionic gonadotropin, beta polypeptide
|
|
COMT
|
catechol-O-methyltransferase
|
|
CS
|
citrate synthase
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
|
CYCS
|
cytochrome c, somatic
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
|
EDN3
|
endothelin 3
|
|
EGFR
|
epidermal growth factor receptor
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
F2
|
coagulation factor II (thrombin)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
FGF9
|
fibroblast growth factor 9
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FSHB
|
follicle stimulating hormone, beta polypeptide
|
|
GOT1
|
glutamic-oxaloacetic transaminase 1, soluble
|
|
HCK
|
HCK proto-oncogene, Src family tyrosine kinase
|
|
HDAC4
|
histone deacetylase 4
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IL1B
|
interleukin 1, beta
|
|
IL6
|
interleukin 6
|
|
INS
|
insulin
|
|
JUN
|
jun proto-oncogene
|
|
LHB
|
luteinizing hormone beta polypeptide
|
|
LPL
|
lipoprotein lipase
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
NFE2L1
|
nuclear factor, erythroid 2-like 1
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
OPRM1
|
opioid receptor, mu 1
|
|
OXT
|
oxytocin/neurophysin I prepropeptide
|
|
PAEP
|
progestagen-associated endometrial protein
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PGR
|
progesterone receptor
|
|
PRKCD
|
protein kinase C, delta
|
|
PRL
|
prolactin
|
|
PTEN
|
phosphatase and tensin homolog
|
|
REN
|
renin
|
|
SCNN1A
|
sodium channel, non voltage gated 1 alpha subunit
|
|
SCNN1B
|
sodium channel, non voltage gated 1 beta subunit
|
|
SCNN1G
|
sodium channel, non voltage gated 1 gamma subunit
|
|
SELP
|
selectin P (granule membrane protein 140kDa, antigen CD62)
|
|
SERPINC1
|
serpin peptidase inhibitor, clade C (antithrombin), member 1
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
TBX3
|
T-box 3
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TH
|
tyrosine hydroxylase
|
|
TNF
|
tumor necrosis factor
|
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A1
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VEGFA
|
vascular endothelial growth factor A
|
